epilepsy Clinical Trials and Research
Also known as: seizure disorder, recurrent seizures, convulsive disorder, epileptic seizures, brain seizure disorder · ICD-10: G40
Epilepsy is a brain disorder characterized by recurrent, unprovoked seizures. Clinical trial research is actively exploring new therapies, diagnostic methods, and ways to better control seizures and improve quality of life. Find a Trial helps patients search for active studies.
Common questions about epilepsy clinical trials
What makes someone eligible for an epilepsy clinical trial?
Eligibility criteria vary greatly by study, often including age, seizure type, frequency, and current medications. Researchers look for participants who fit specific health profiles to ensure study safety and valid results, according to information on ClinicalTrials.gov.
What are the different phases of epilepsy clinical trials?
Clinical trials typically progress through phases, starting with small safety studies (Phase 1) and expanding to larger groups to test effectiveness and monitor side effects (Phases 2 and 3). Phase 4 studies occur after a treatment is approved, as outlined on ClinicalTrials.gov.
Do clinical trials for epilepsy cost money to participate?
Generally, participants do not pay for study-related treatments or procedures in clinical trials. Some studies may even cover travel or other expenses, but this varies. Always confirm financial details with the research team, as noted on ClinicalTrials.gov.
What are some active research directions in epilepsy clinical trials?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, focuses on novel anti-seizure medications, gene therapies, neuromodulation devices, and precision medicine approaches tailored to individual seizure types. Studies also explore non-pharmacological interventions and diagnostic tools.
What types of interventions are being studied in epilepsy trials?
Interventions include new oral medications, injectable drugs, surgical techniques, vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS). Dietary therapies and behavioral interventions are also under investigation, according to ClinicalTrials.gov.
Are there specific biomarkers being investigated in epilepsy research?
Researchers are exploring genetic markers, imaging findings (like MRI abnormalities), and electrophysiological patterns (EEG) as potential biomarkers to predict seizure risk, treatment response, or disease progression. This data helps personalize epilepsy care, as shown on NIH RePORTER.
What are common reasons someone might be excluded from an epilepsy trial?
Common exclusion criteria can include specific co-existing medical conditions, pregnancy, certain medications that interact with the study drug, or a history of drug resistance to previous treatments. These criteria ensure participant safety and study integrity, per ClinicalTrials.gov.
Are there clinical trials specifically for children with epilepsy?
Yes, many clinical trials are designed specifically for pediatric populations with epilepsy. These studies investigate treatments and interventions tailored to children's unique needs and developmental stages, as evidenced by listings on ClinicalTrials.gov and NIH RePORTER.
How to find a epilepsy trial that fits you
- Describe your epilepsy situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.